当前位置： SCI文献检索 > International Journal of Clinical Oncology期刊下所有文献 > The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen.

The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen.

Abstract：

BACKGROUND:Our aim was to study the efficacy and safety of combination chemotherapy with gemcitabine plus cisplatin (GC) for patients with advanced urothelial carcinoma (UC) after failure of methotrexate, vinblastin, adriamycin, and cisplatin (M-VAC) chemotherapy. METHODS:We studied a total of 33 patients with advanced UC. All patients were treated with M-VAC with a mean of 3.2 courses per patient and had showed disease progression or no response. Clinical and pathological features were correlated to survival rates, and the incidence and degree of toxicities were also retrospectively reviewed. RESULTS:A total of 132 courses of GC with a mean of 4.0 courses per patients were undergone. Two (6.0%) complete responses and 11 (33.3%) partial responses produced an overall response rate of 39.4%. In 55 assessable lesions, there were 2 (4%) complete responses, 13 (23%) partial responses, 31 (55%) with stable disease, and 10 (18%) with progressive disease. Overall, mean of survival time after GC chemotherapy was 10.5 months (range, 3.0-22.9 months). In univariate analysis, the patients with higher serum hemoglobin or single metastasis or no liver metastasis tended to survive longer than those with lower hemoglobin or multiple metastases or existence of liver metastasis. Although grade 3-4 neutropenia was seen in 22 patients (66.7%) and grade 3-4 thrombocytopenia was seen in 10 patients (30.3%), fatal side effects were not observed. CONCLUSIONS:The combination chemotherapy with GC seems feasible with no severe side effects and may provide a survival benefit for patients with advanced UC after failure of M-VAC chemotherapy.

journal_name

Int J Clin Oncol

journal_title

International journal of clinical oncology

authors

Gondo T,Ohori M,Hamada R,Tanaka A,Satake N,Takeuchi H,Nakashima J,Hatano T,Tachibana M

doi

10.1007/s10147-011-0188-4

subject

Has Abstract

pub_date

2011-08-01 00:00:00

pages

345-51

issue

4

eissn

1341-9625

issn

1437-7772

journal_volume

16

pub_type

临床试验,杂志文章

相关文献

International Journal of Clinical Oncology文献大全
  • Serum HER2 levels determined by two methods in patients with metastatic breast cancer.

    abstract：BACKGROUND:The role and the optimal measurement method of serum HER2 levels are not defined in patients with metastatic breast cancer (MBC). We prospectively assessed the prognostic value of serum HER2 levels in MBC using two methods, enzyme immunoassay (EIA) and chemiluminescence immunoassay (CLIA). METHODS:We collec...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-011-0253-z

    authors： Hayashi N,Nakamura S,Tokuda Y,Yagata H,Yoshida A,Ota H,Hortobagyi GN,Cristofanilli M,Ueno NT

    更新日期：2012-02-01 00:00:00

  • Motor dominant neuropathy induced by adjuvant therapy with adriamycin and cyclophosphamide followed by dose-dense paclitaxel in a breast cancer patient.

    abstract：:A 38-year-old woman underwent mastectomy and axillary lymph node dissection for invasive ductal carcinoma with multiple lymph node involvement. The patient received adriamycin 60 mg/m(2) and cyclophosphamide 600 mg/m(2) followed by weekly paclitaxel 80 mg/m(2) (without interruption) as adjuvant treatment. After receiv...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0578-1

    authors： Hikino H,Kawashima M,Yamada T,Ozaki N

    更新日期：2006-08-01 00:00:00

  • The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer.

    abstract：BACKGROUND:The standard treatment for cervical cancer is chemoradiation although some patients showed treatment resistance. The purpose of this study was to investigate the clinical efficacy of surgery after chemoradiation for cervical cancer. METHODS:Patients with FIGO stage IB2 to IIB cervical cancer were included i...

    journal_title：International journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s10147-019-01551-6

    authors： Yoshida K,Kajiyama H,Yoshihara M,Tamauchi S,Ikeda Y,Yoshikawa N,Nishino K,Niimi K,Suzuki S,Kikkawa F

    更新日期：2020-02-01 00:00:00

  • A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1.

    abstract：:We report the case of a 62-year-old man with advanced gastric cancer and multiple liver metastases who was successfully treated with combined chemotherapy including S-1. The patient was clinically diagnosed with stage IV (T3 N2 H1 P0) disease and was initially treated with 100 mg/body per day S-1 administered orally f...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0648-4

    authors： Nakamura R,Saikawa Y,Kumagai K,Kiyota T,Ohashi M,Yoshida M,Kubota T,Kumai K,Kitajima M

    更新日期：2007-08-01 00:00:00

  • Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast.

    abstract：:We report a patient with avascular necrosis of the bilateral femoral head resulting from long-term steroid administration for radiation pneumonitis that occurred after tangential irradiation of the breast. The patient was a 50-year-old postmenopausal woman with breast cancer, stage IIIB (T4bN0M0) in the right C area. ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0607-0

    authors： Kosaka Y,Mitsumori M,Araki N,Yamauchi C,Nagata Y,Hiraoka M,Kodama H

    更新日期：2006-12-01 00:00:00

  • Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay.

    abstract：BACKGROUND:The present study investigated whether treatment with anginex, a novel antiangiogenic peptide, could block re-vascularization after radiation treatment. METHODS:A squamous cell (SCCVII) xenograft tumor mouse model was employed to assess the effects of anginex given post-radiation on tumor growth, microvesse...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0625-y

    authors： Amano M,Suzuki M,Andoh S,Monzen H,Terai K,Williams B,Song CW,Mayo KH,Hasegawa T,Dings RP,Griffin RJ

    更新日期：2007-02-01 00:00:00

  • Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer.

    abstract：BACKGROUND:The risk factors of incisional surgical site infection (iSSI) after open radical cystectomy (ORC) have not been fully investigated. The aim of the present study is to examine factors correlated with iSSI development after ORC with intestinal urinary diversion. METHODS:A total of 178 patients who had undergo...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-013-0646-2

    authors： Gondo T,Ohno Y,Nakashima J,Hashimoto T,Takizawa I,Tanaka A,Shimodaira K,Satake N,Takeuchi H,Nakagami Y,Ohori M,Tachibana M

    更新日期：2014-10-01 00:00:00

  • Multiple lymphomatous polyposis overexpressing cyclin D1.

    abstract：:A case of mantle cell lymphoma (MCL) associated with multiple lymphomatous polyposis (MLP) is reported is a 62-year-old woman, with special reference to the patient's clinical features and response to treatment. There were multiple widespread polypoid lesions in the entire gastrointestinal tract, with ileocecal masses...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s101470050012

    authors： Tsujimura H,Takagi T,Tamaru J,Sakai C

    更新日期：2000-02-01 00:00:00

  • Four cases of advanced renal cell carcinoma with pancreatic metastasis successfully treated with radiation therapy.

    abstract：:We report four patients with pancreatic metastasis of renal cell carcinoma who were successfully treated with radiation therapy. The patients were one woman and three men with a median age of 55 years (range, 49 to 62 years) who underwent radical nephrectomy for primary renal cell carcinoma. The median interval from n...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-008-0833-8

    authors： Saito J,Yamanaka K,Sato M,Mori N,Sekii K,Yoshioka T,Itatani H,Nakatsuka S

    更新日期：2009-06-01 00:00:00

  • Testicular metastasis from an extramedullary plasmacytoma.

    abstract：:Plasmacytoma is a blood disease featuring the proliferation of abnormal plasmacytes accompanied by the production of monoclonal immunoglobulins. It usually arises in the medulla; thus, extramedullary plasmacytoma is rare, and metastatic testicular tumors are also infrequent. In this report, we present a case of testic...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-008-0769-z

    authors： Kamisawa H,Akita H,Naiki T,Kato T,Okamura T

    更新日期：2008-10-01 00:00:00

  • Long-term results and prognostic factors in patients with stage III-IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study.

    abstract：BACKGROUND:We evaluated the longer-term efficacy and safety of concurrent chemoradiotherapy (CCRT) incorporating high-dose-rate intracavitary brachytherapy (HDR-ICBT) with a lower cumulative radiotherapy (RT) protocol and analyzed prognostic risk factors for survival among patients with FIGO stage III-IVA squamous cell...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-012-0457-x

    authors： Kudaka W,Nagai Y,Toita T,Inamine M,Asato K,Nakamoto T,Wakayama A,Ooyama T,Tokura A,Murayama S,Aoki Y

    更新日期：2013-10-01 00:00:00

  • Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).

    abstract：BACKGROUND:Older or frail patients are often underrepresented in clinical trials for metastatic colorectal cancer (mCRC). We here assessed the efficacy and safety of 5-fluorouracil (5-FU)-leucovorin plus bevacizumab in such patients. METHODS:The study (OGSG 0802) was designed as a single-arm, open-label, multicenter p...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s10147-020-01656-3

    authors： Ohta T,Kato T,Kawakami H,Miyake Y,Goto M,Iwamoto S,Otsuji T,Nakamura M,Sugimoto N,Okamura S,Kotaka M,Tsujie M,Tokunaga Y,Mishima H,Hata T,Shimokawa T,Kurokawa Y,Satoh T

    更新日期：2020-07-01 00:00:00

  • Gastrectomy and chemotherapy with S-1 for gastric cancer in a patient with acquired immunodeficiency syndrome.

    abstract：:Total gastrectomy and chemotherapy with S-1 after surgery were performed in a 50-year-old woman with gastric cancer associated with acquired immunodeficiency syndrome (AIDS). She was given a diagnosis of gastric cancer at the lesser curvature of the body of the stomach, and distal gastrectomy was performed in December...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-010-0114-1

    authors： Suzuki R,Ariizumi S,Araida T,Hayashi K,Yamamoto M

    更新日期：2011-02-01 00:00:00

  • Performance of outpatient regimen of S-1 in combination with fractional cisplatin for advanced or recurrent gastric cancers: a phase I study.

    abstract：BACKGROUND:We designed an outpatient regimen consisting of fractional cisplatin in combination with S-1, a novel oral fluoropyrimidine derivative for the treatment of recurrent or advanced gastric cancer and conducted a phase I study to determine the dose limiting toxicities (DLTs) and recommended dose (RD). METHODS:E...

    journal_title：International journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s10147-005-0505-x

    authors： Shimoyama S,Imamura K,Hiki N,Yamaguchi H,Mafune K,Kaminishi M

    更新日期：2005-08-01 00:00:00

  • Non-muscle invasive bladder cancer with concomitant vaginal urothelial carcinoma: a case report and review of the literature.

    abstract：:A 74-year-old female was referred to our hospital for non-muscle invasive bladder tumors initially treated at another hospital. Preoperatively, computed tomography and magnetic resonance imaging demonstrated non-muscle invasive bladder tumors and a vaginal tumor. A second transurethral resection of the bladder tumors,...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-010-0097-y

    authors： Kaneko G,Kikuchi E,Hasegawa M,Miyajima A,Nakagawa K,Kameyama K,Oya M

    更新日期：2010-12-01 00:00:00

  • Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors.

    abstract：BACKGROUND:The efficacy of individual chemotherapy based on chemosensitivity has scarcely been studied. METHODS:We examined the chemosensitivites for four anticancer agents - 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3 (2-chloroethyl)-3-nitrosourea hydrochloride (ACNU), carboplatin, cisplatin, and etoposide - of 43 ma...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0636-8

    authors： Ono A,Kanno H,Hayashi A,Nishimura S,Kyuma Y,Sato H,Ito S,Shimizu N,Chang CC,Gondo G,Yamamoto I,Sasaki T,Tanaka M

    更新日期：2007-04-01 00:00:00

  • Clinical features and treatment strategy for HPV-related oropharyngeal cancer.

    abstract：:Among head and neck squamous cell carcinoma (HNSCC), the incidence of oropharyngeal SCC (OPSCC) is increasing in contrast to carcinoma with origin in other subsites. Human papillomavirus (HPV) is now recognized as a significant risk factor of the carcinogenesis of OPSCC. The HPV-related OPSCC patients tend to be relat...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1007/s10147-016-1009-6

    authors： Okami K

    更新日期：2016-10-01 00:00:00

  • Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.

    abstract：:The identification and validation of putative surrogate endpoints in oncology is a great challenge to medical investigators, statisticians, and regulators. A putative surrogate endpoint must be validated at both individual-level and trial-level before it can be used to replace the clinical endpoint in a future clinica...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1007/s10147-009-0885-4

    authors： Shi Q,Sargent DJ

    更新日期：2009-04-01 00:00:00

  • Comparison of outcomes between overlapping structure-based and non-overlapping structure-based optimization for simultaneous integrated boost IMRT for malignant gliomas.

    abstract：BACKGROUND:Intensity-modulated radiotherapy (IMRT) can deliver different doses to two target volumes with high conformity. The purpose of the present study was to compare outcomes provided by two different optimization methods, overlapping structure-based and non-overlapping structure-based methods, for simultaneous in...

    journal_title：International journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s10147-004-0433-1

    authors： Suzuki M,Nakamatsu K,Kanamori S,Okajima K,Okumura M,Nishimura Y

    更新日期：2004-12-01 00:00:00

  • CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.

    abstract：BACKGROUND:The CpG island methylator phenotype (CIMP) with multiple promoter methylated loci has been observed in a subset of human colorectal cancer (CRC) cases. CIMP status, which is closely associated with specific clinicopathological and molecular characteristics, is considered a potential predictive biomarker for ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-016-1017-6

    authors： Zhang X,Shimodaira H,Soeda H,Komine K,Takahashi H,Ouchi K,Inoue M,Takahashi M,Takahashi S,Ishioka C

    更新日期：2016-12-01 00:00:00

  • Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial.

    abstract：BACKGROUND:The aim of this phase II study was to evaluate the feasibility and safety of a carboplatin and gemcitabine combination regimen in the treatment of completely resected non-small cell lung cancer (NSCLC). METHODS:Patients with completely resected pathologically documented stage IB, II or IIIA NSCLC were treat...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-010-0118-x

    authors： Usami N,Yokoi K,Hasegawa Y,Taniguchi H,Shindo J,Yamamoto M,Suzuki R,Imaizumi K,Kondo M,Shimokata K,Central Japan Lung Study Group.

    更新日期：2010-12-01 00:00:00

  • A new therapeutic approach in patients with advanced sarcoma.

    abstract：:Sarcomas represent a rare and heterogeneous disease and the prognosis of patients remains poor, with a disease-free survival at 5 years of less than 10%. Only a few chemotherapeutic agents, such as doxorubicin and ifosfamide, have been identified to be active with response rates above 20%. The concept of angiostatic t...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-005-0514-9

    authors： Kasper B,Ho AD,Egerer G

    更新日期：2005-12-01 00:00:00

  • Reconstruction surgery for patients with musculoskeletal tumor, using a pasteurized autogenous bone graft.

    abstract：BACKGROUND:The pasteurized autogenous bone graft (PABG) is a new method to reuse resected and diseased autogenous bones after heat treatment at a comparatively low temperature (60 degrees C-65 degrees C). METHODS:The subjects of this study were ten patients with musculoskeletal tumor who underwent surgery with a PABG ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-004-0391-7

    authors： Sakayama K,Kidani T,Fujibuchi T,Kamogawa J,Yamamoto H,Shibata T

    更新日期：2004-06-01 00:00:00

  • Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

    abstract：BACKGROUND:Neoadjuvant cisplatin-based chemotherapy for patients with muscle-invasive bladder cancer (BC) has better survival benefit than radical cystectomy (RC) alone. However, optimal dosing schedule, including drug selection, number of cycles, and interval between chemotherapy and cystectomy, as well as acceptable ...

    journal_title：International journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s10147-012-0447-z

    authors： Koie T,Ohyama C,Hashimoto Y,Hatakeyama S,Yamamoto H,Yoneyama T,Kamimura N

    更新日期：2013-08-01 00:00:00

  • Relapse patterns of localized non-Hodgkin's lymphoma of the head and neck after clinical remission: results of a strict follow-up procedure.

    abstract：BACKGROUND:No effective follow-up strategy for non-Hodgkin's lymphoma (NHL) has been identified to date. The aim of this study was to assess the value of a strict follow-up procedure in patients with NHL after they showed clinical remission. METHODS:One hundred and twenty-one patients with localized NHL of the head an...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-001-8032-x

    authors： Nakamura K,Sasaki M,Kunitake N,Kimura M,Watanabe T,Sasaki T,Terashima H,Kuwabara Y,Sakai S,Masuda K

    更新日期：2001-12-01 00:00:00

  • Strategies for dealing with fraud in clinical trials.

    abstract：:Research misconduct and fraud in clinical research is an increasing problem facing the scientific community. This problem is expected to increase due to discoveries in central statistical monitoring and with the increase in first-time clinical trial investigators in the increasingly global reach of oncology clinical t...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1007/s10147-015-0876-6

    authors： Herson J

    更新日期：2016-02-01 00:00:00

  • The evolving role of aromatase inhibitors in breast cancer.

    abstract：:Anti-aromatase agents inhibit the cytochrome p-450 component of the aromatase enzyme complex responsible for the final step of estrogen biosynthesis in peripheral tissues. These drugs can be classified into first-generation (e.g., aminoglutethimide), second-generation (e.g., formestane and fadrazole), and third-genera...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1007/s101470200040

    authors： Mokbel K

    更新日期：2002-10-01 00:00:00

  • The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study.

    abstract：BACKGROUND:Recent studies have shown that immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs) were correlated with favorable clinical outcome in patients with melanoma. However, in metastatic renal cell carcinoma (mRCC) patients, there have been few reports about the correlation between ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-021-01872-5

    authors： Kato T,Nagahara A,Kawamura N,Nakata W,Soda T,Matsuzaki K,Hatano K,Kawashima A,Ujike T,Imamura R,Nishimura K,Takada S,Tsujihata M,Yamaguchi S,Takao T,Nishimura K,Nonomura N,Uemura M

    更新日期：2021-01-20 00:00:00

  • Treatment outcomes of hypofractionated radiotherapy combined with temozolomide followed by bevacizumab salvage therapy in glioblastoma patients aged > 75 years.

    abstract：BACKGROUND:The optimal treatment for elderly patients with glioblastoma has not been established. METHODS:We retrospectively analyzed the safety and efficacy of hypofractionated radiotherapy (45 Gy/15 fr) combined with temozolomide (TMZ) followed by bevacizumab (BEV) salvage treatment in 18 glioblastoma patients aged ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-018-1298-z

    authors： Matsuda KI,Sakurada K,Nemoto K,Kayama T,Sonoda Y

    更新日期：2018-10-01 00:00:00

  • Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.

    abstract：BACKGROUND:Inhibition of Notch by γ-secretase inhibitor (GSI) has been shown to have an antitumor effect in Notch-expressing non-small cell lung cancer (NSCLC) and to induce apoptosis through modulation of Bcl-2 family proteins. In particular, Bim, a BH3-only member of the Bcl-2 family of proteins, has an important rol...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-016-1060-3

    authors： Sakakibara-Konishi J,Ikezawa Y,Oizumi S,Kikuchi J,Kikuchi E,Mizugaki H,Kinoshita I,Dosaka-Akita H,Nishimura M

    更新日期：2017-04-01 00:00:00